An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant Recipients

计划入组 30 人 · 首次发布于 2022 年 3 月 24 日

Role of Anti-BK Virus Neutralizing Antibodies (BKV) as a Prognostic Marker for the Development of Nephropathy BK

计划入组 170 人 · 首次发布于 2016 年 7 月 11 日

Intravenous Immunoglobulins for Prevention of BKV Infection in Kidney Transplant Recipients According to BKV Genotype-specific Neutralizing Antibody Titers at the Day of Transplantation.

计划入组 359 人 · 首次发布于 2020 年 1 月 9 日

HYB BKV

AIC-468

Diabetic nephropathy stem cell therapy (Kidswell Bio)

Calliditas Therapeutics

Sweden

Zhejiang Anglikang Pharmaceutical Co.,Ltd.

China

Hunan Nucien Pharmaceutical Co., Ltd.

Memo Therapeutics Demonstrates Therapeutic Antibodies Can Cross Kidney Barrier, Supporting BK Virus Treatment Approach

Memo Therapeutics Completes Enrollment in Phase II Trial of Potravitug for BK Viremia

Memo Therapeutics AG Completes Enrollment in Phase II Trial of Potravitug for BK Viremia